FindTrial
Sign In

TO STUDY THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AS A MEASURE OF SUGAR CONTROL AS COMPARED TO STANDARD TEST OF GLYHB.

EVALUATION OF ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AS A MARKER OF INFLAMMATORY STATE AND BLOOD SUGAR CONTROL IN TYPE 2 DIABETES.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/03/008089
Enrollment
100
Registered
2017-03-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS WITH TYPE 2 DIABETES

Interventions

None listed

Sponsors

KASTURBA HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Type 2 Diabetes admitted in kasturba hospital who have given informed consent.

Exclusion criteria

Exclusion criteria: Acute/chronic inflammatory states,acute/chronic kidney disease,chronic liver disease,leukemia,lymphoma,malignancies.

Design outcomes

Primary

MeasureTime frame
To evaluate role of neutrophil to lymphocyte ratio as a marker of inflammatory state and blood sugar control in type 2 diabetes.Timepoint: NOVEMBER 2018—

Secondary

MeasureTime frame
To study the association of HsCRP and GlyHb in type 2 diabetesTimepoint: NOVEMBER 2018—

Countries

India

Contacts

Public ContactPOORNIMA S TADKAL

KASTURBA HOSPITAL

rvacharya@manipal.edu9854571000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026